950455-15-9

Liproxstatin-1 是一种有效的 ferroptosis 抑制剂。

Liproxstatin-1 is able to inhibit ferroptosis in the low nanomolar range and inhibit the growth of Gpx4^−/−cells with IC50 of 22 nM. Liproxstatin-1 (50 nM) completely prevents lipid peroxidation in Gpx4^−/−cells. Liproxstatin-1 (200 nM) protects against FINs, such as BSO (10 µM), erastin (1 µM) and RSL3 (0.5 µM), in a dose dependent manner, whereas it fails to rescue cell death induced by staurosporine (0.2 µM) and H₂O₂ (200 µM).

Liproxstatin-1 remarkably extends survival compared with the vehicle-treated group, delays ferroptosis in tubular cells, and mitigates tissue injury in ischaemia/reperfusion-induced liver injury.

Liproxstatin-1是一种有效的ferroptosis抑制剂，IC50为22 nM。

Target	Value
ferroptosis (Cell-free assay)	22 nM

Liproxstatin-1能够在低纳摩尔范围内抑制铁死亡和Gpx4

与溶剂对照组相比，Liproxstatin-1可显著地延长生存期，抑制管状细胞中铁死亡，减轻缺血/再灌注诱发的肝损伤中的组织损伤。